| Metric | H2 FY26 | H1 FY26 | H2 FY25 |
|---|---|---|---|
| Revenue from operations | 0.0 | 25.5 | 11.8 |
| Other income | 0.2 | 1.1 | 2.4 |
| Total income | 0.2 | 26.6 | 14.2 |
| Profit before exceptional items & tax | -0.3 | 0.1 | 1.8 |
| Profit before tax | -0.3 | 0.1 | 1.8 |
| Net profit | -0.3 | 0.1 | 1.7 |
| Operating margin | -150.0% | 0.4% | 12.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
Source
Read the filing ↗
BSE results filing, BSE: 543500. Figures extracted from the filing.
Evoq Remedies Ltd: key numbers
- Share price
- ₹1.46
- Market cap
- ₹3.64 Cr
- Revenue (annual)
- ₹25.51 Cr
- Net profit (annual)
- ₹-0.24 Cr
- P/E (TTM)
- -15.2×Sector 57.8×
- Promoter holding
- 0.02%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.